Tone down MRA (mutual recognition agreement) demands EU tells Canada and Australia
This article was originally published in Clinica
Medical device representatives from the European Union have told the Australian and Canadian authorities about their tendency to overpolice aspects of the forthcoming trade agreements with the EU. The EU has told the trading partners of its concern.
You may also be interested in...
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.
AstraZeneca's research head admits that the half dose approach was a lucky mistake – but one that could boost the vaccine's effectiveness and supplies. The US regulator may not be persuaded, however.